A detailed history of Exane Derivatives transactions in National Health Investors Inc stock. As of the latest transaction made, Exane Derivatives holds 7 shares of NHI stock, worth $542. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 7 -0.0%
Holding current value
$542
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 27, 2021

SELL
$54.6 - $71.04 $7,207 - $9,377
-132 Reduced 94.96%
7 $0
Q2 2020

Jul 10, 2020

SELL
$37.6 - $68.11 $81,253 - $147,185
-2,161 Reduced 93.96%
139 $8,000
Q1 2020

Apr 17, 2020

BUY
$33.56 - $90.79 $77,188 - $208,817
2,300 New
2,300 $113,000
Q3 2018

Oct 24, 2018

SELL
$73.29 - $79.25 $146 - $158
-2 Closed
0 $0
Q2 2018

Jul 19, 2018

SELL
$65.51 - $75.01 $282,741 - $323,743
-4,316 Reduced 99.95%
2 $0
Q1 2018

Apr 30, 2018

SELL
$63.33 - $75.78 $82,835 - $99,120
-1,308 Reduced 23.25%
4,318 $0
Q4 2017

Jan 29, 2018

SELL
$75.38 - $80.81 $203,526 - $218,187
-2,700 Reduced 32.43%
5,626 $0
Q3 2017

Oct 18, 2017

BUY
$75.37 - $80.64 $627,530 - $671,408
8,326
8,326 $0

Others Institutions Holding NHI

About NATIONAL HEALTH INVESTORS INC


  • Ticker NHI
  • Exchange NYSE
  • Sector Real Estate
  • Industry REIT—Healthcare Facilities
  • Shares Outstandng 44,655,200
  • Market Cap $3.46B
  • Description
  • Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee re...
More about NHI
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.